MAPT and Cognitive impairment: These effects were more evident in patients with abnormal CSF Aβ levels, indicating that, in the presence of Aβ pathology, associations between cerebrovascular, neurodegenerative, and neuroinflammatory processes may be aggravated and contribute to tau aggregation, leading to cognitive impairment and disease progression [71].